A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma

10th Int. Conference on Bioinformatics - 1st ISCB Asia Joint Conference 2011, InCoB 2011/ISCB-Asia 2011: Computational Biology - Proceedings from Asia Pacific Bioinformatics Network (APBioNet)

Volumn 12, Issue SUPPL. 3, 2011, Pages

  Toh, Swee Heng ^a   Prathipati, Philip ^a   Motakis, Efthimios ^a   Keong, Kwoh Chee ^b   Yenamandra, Surya Pavan ^a   Kuznetsov, Vladimir A ^a  

^a BIOINFORMATICS INSTITUTE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AFFYMETRIX; ANALYTICAL METHOD; CANCER CELLS; CELL COMMUNICATION; CELL MOTILITY; CLINICAL BIOMARKERS; DATA SETS; EARLY DIAGNOSIS; EXPRESSED GENES; FEATURE SELECTION METHODS; GENE EXPRESSION PROFILING; GENE GROUPS; GENETIC MECHANISM; HUMAN LUNG; IMMUNE SYSTEMS; LUNG CANCER; LUNG TISSUE; METABOLIC PATHWAYS; MITOTIC CELLS; PAIRED SAMPLE; SMALL SAMPLE SIZE; STATISTICAL MODELLING; TRANSCRIPTOMES; WILCOXON TEST;

BIOLOGICAL ORGANS; BIOMARKERS; CELLS; CLUSTER ANALYSIS; CYTOLOGY; DIAGNOSIS; DISEASES; FACE RECOGNITION; GENE EXPRESSION; HISTOLOGY; IMMUNOLOGY; TUMORS;

BIOINFORMATICS;

TUMOR MARKER;

ADENOCARCINOMA; ALGORITHM; ARTICLE; BIOLOGY; CLUSTER ANALYSIS; DISCRIMINANT ANALYSIS; DNA MICROARRAY; FACTUAL DATABASE; GENETICS; HUMAN; LUNG; LUNG TUMOR; METABOLISM; METHODOLOGY; PROGNOSIS;

ADENOCARCINOMA; ALGORITHMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DISCRIMINANT ANALYSIS; HUMANS; LUNG; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862263982     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1186/1471-2164-12-S3-S24     Document Type: Conference Paper

References (72)

1. Kobayashi K, Nishioka M, Kohno T, Nakamoto M, Maeshima A, Aoyagi K, Sasaki H, Takenoshita S, Sugimura H, Yokota J: Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo. Oncogene 2004, 23:3089-3096.
2. Nakamura N, Kobayashi K, Nakamoto M, Kohno T, Sasaki H, Matsuno Y, Yokota J: Identification of tumor markers and differentiation markers for molecular diagnosis of lung adenocarcinoma. Oncogene 2006, 25:4245-4255.
3. Kuznetsov V, Thomas S, Bonchev D: Data-driven networking reveals 5- genes signature for early detection of lung cancer. In International Conference on BioMedical Engineering and Informatics, 2008. Volume 1. IEEE; 2008:413-417.
4. Ahmedin J, Rebecca S, Elizabeth W, Yongping H, Jiaquan X, et al: Cancer statistics. A Cancer Journal for Clinicians 2009, Published online before print May 27, 2009.
5. Ahmedin J, Rebecca S, Jiaquan X, Elizabeth W: Cancer Statistics. Ca Cancer J Clin 2010, 60:5.
6. Subramanian J, Simon R: Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J. Natl. Cancer Inst 2010, 102:464-474.
7. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC, Grosveld F, Philipsen S: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS ONE 2010, 5:e10312.
8. Guo NL, Wan YW, Tosun K, Lin H, Msiska Z, Flynn DC, Remick SC, Vallyathan V, Dowlati A, Shi X, Castranova V, Beer DG, Qian Y: Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res 2008, 14(24):8213-20.
9. Popławski AB, Jankowski M, Erickson SW, Díaz de Ståhl T, Partridge EC, Crasto C, Guo J, Gibson J, Menzel U, Bruder CE, Kaczmarczyk A, Benetkiewicz M, Andersson R, Sandgren J, Zegarska B, Bała D, Srutek E, Allison DB, Piotrowski A, Zegarski W, Dumanski JP: Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. Eur. J. Hum. Genet 2010, 18:560-568.
10. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y: The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat. Rev. Cancer 2008, 8:37-49.
11. Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H, Hoffmann H: Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009, 63:32-38.
12. Lesko LJ, Atkinson AJ Jr.: Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu. Rev. Pharmacol. Toxicol 2001, 41:347-366.
13. Singhal S, Miller D, Ramalingam S, Sun SY: Gene expression profiling of non-small cell lung cancer. Lung Cancer 2008, 60:313-324.
14. Mack PC, Redman MW, Chansky K, Williamson SK, Farneth NC, Lara PN Jr., Franklin WA, Le QT, Crowley JJ, Gandara DR: Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003. J. Clin. Oncol 2008, 26:4771-4776.
15. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJW, Yang PC: A five-gene signature and clinical outcome in nonsmall- cell lung cancer. N. Engl. J. Med 2007, 356:11-20.
16. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
17. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P: Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 2002, 21:7749-7763.
18. Smith SL, Gugger M, Hoban P, Ratschiller D, Watson SG, Field JK, Betticher DC, Heighway J: S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Br. J. Cancer 2004, 91:1515-1524.
19. Wang H, Zhang Z, Li R, Ang KK, Zhang H, Caraway NP, Katz RL, Jiang F: Overexpression of S100A2 protein as a prognostic marker for patients with stage I non-small cell lung cancer. Int. J. Cancer 2005, 116:285-290.
20. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J: Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 2009, 63:410-417.
21. Hanada S, Maeshima A, Matsuno Y, Ohta T, Ohki M, Yoshida T, Hayashi Y, Yoshizawa Y, Hirohashi S, Sakamoto M: Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression. J. Pathol 2008, 216:75-82.
22. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF: Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol. Biomarkers Prev 2008, 17:995-1000.
23. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF: Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol. Biomarkers Prev 2008, 17:995-1000.
24. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA, Morrison CD, Smiraglia DJ, Plass C: Epigenetic regulation of the tumours suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl. Acad. Sci. U.S.A 2006, 103:982-987.
25. Arima T, Yamamoto M, Hirata A, Kawano S, Kamada T: The eln3 gene involved in fruiting body morphogenesis of Coprinus cinereus encodes a putative membrane protein with a general glycosyltransferase domain. Fungal Genet. Biol 2004, 41:805-812.
26. Latil A, Bièche I, Chêne L, Laurendeau I, Berthon P, Cussenot O, Vidaud M: Gene expression profiling in clinically localized prostate cancer: a fourgene expression model predicts clinical behaviour. Clin. Cancer Res 2003, 9:5477-5485.
27. Edwards J, Krishna NS, Grigor KM, Bartlett JMS: Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br. J. Cancer 2003, 89:552-556.
28. Haney S, Kam M, Hrebien L: Benefits of using paired controls for analysing gene expression of prostate cancer. In 8th IEEE International Conference on BioInformatics and BioEngineering, 2008. BIBE 2008. Volume 2008. IEEE;1-3.
29. Tan Q, Thomassen M, Kruse TA: Feature selection for predicting tumours metastases in microarray experiments using paired design. Cancer Inform 2007, 3:213-218.
30. Lisovich A, Chandran UR, Lyons-Weiler MA, LaFramboise WA, Brown AR, Jakacki RI, Pollack IF, Sobol RW: A novel SNP analysis method to detect copy number alterations with an unbiased reference signal directly from tumours samples. BMC Med Genomics 2011, 4:14.
31. Heinrichs S, Li C, Look AT: SNP array analysis in hematologic malignancies: avoiding false discoveries. Blood 2010, 115:4157-4161.
32. Wu LY, Zhou X, Li F, Yang X, Chang CC, Wong STC: Conditional random pattern algorithm for LOH inference and segmentation. Bioinformatics 2009, 25:61-67.
33. Quackenbush J: Computational analysis of microarray data. Nat. Rev. Genet 2001, 2:418-427.
34. Storey JD, Xiao W, Leek JT, Tompkins RG, Davis RW: Significance analysis of time course microarray experiments. Proc. Natl. Acad. Sci. U.S.A 2005, 102:12837-12842.
35. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3, Article3.
36. Welch BL: On the comparison of several mean values: an alternative approach. Biometrika 1951, 38:330-336.
37. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A 2001, 98:5116-5121.
38. Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH, Huang CYF: Selection of DDX5 as a novel internal control for Q-QRT-PCR from microarray data using a block bootstrap resampling scheme. BMC Genomics 2007, 8:140.
39. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez- Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK: Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455:1069-1075.
40. Zhu CQ, Shih W, Ling CH, Tsao MS: Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J. Clin. Pathol 2006, 59:790-800.
41. Giaccone G, Zucali PA: Src as a potential therapeutic target in non-smallcell lung cancer. Ann. Oncol 2008, 19:1219-1223.
42. Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, Wang X, Duan CJ, Wu NM, Guo ZQ, Liu YX, Liu HN, Wang YY, Wang J: Epidermal growth factor receptor mutations in plasma DNA samples predict tumours response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. J. Clin. Oncol 2009, 27:2653-2659.
43. Franovic A, Holterman CE, Payette J, Lee S: Human cancers converge at the HIF-2alpha oncogenic axis. Proc. Natl. Acad. Sci. U.S.A 2009, 106:21306-21311.
44. Di Maio M, Gridelli C, Normanno N, Perrone F, Ciardiello F: Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. J. Cell. Physiol 2005, 205:355-363.
45. Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, Semeraro A, Del Sordo R, Tofanetti FR, Mameli MG, Daddi G, Cavaliere A, Tonato M, Crinò L: High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann. Oncol 2009, 20:842-849.
46. Gnjatic S: Immunogenic targets in non-small cell lung cancer: more is more. Clin. Cancer Res 2005, 11:5331-5332.
47. Nakagawa K, Noguchi Y, Uenaka A, Sato S, Okumura H, Tanaka M, Shimono M, Ali Eldib AM, Ono T, Ohara N, Yoshino T, Yamashita K, Tsunoda T, Aoe M, Shimizu N, Nakayama E: XAGE-1 expression in nonsmall cell lung cancer and antibody response in patients. Clin. Cancer Res 2005, 11:5496-5503.
48. Sato S, Noguchi Y, Ohara N, Uenaka A, Shimono M, Nakagawa K, Koizumi F, Ishida T, Yoshino T, Shiratori Y, Nakayama E: Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors. Cancer Immun 2007, 7:5.
49. Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, Son D-S, Jo J, Kim J, Lee J, Kim J, Kim K, Lee S: Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res 2007, 67:7431-7438.
50. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A 2001, 98:13790-13795.
51. Chu G, Narasimhan B, Tibshirani R, Tusher V: Significant analysis of microarrays. Users Guide and Technical Document, Technical Report. Department of Biological Science, University of Tulsa, USA.
52. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U.S. A 2002, 99:6567-6572.
53. Tennant DA, Duran RV, Boulahbel H, Gottlieb E: Metabolic transformation in cancer. Carcinogenesis 2009, 30:1269-1280.
54. Tennant DA, Durán RV, Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 2010, 10:267-277.
55. Fisher's Exact Test. [http://www.langsrud.com/stat/fisher.htm].
56. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet 2000, 25:25-29.
57. M Valdivia M, Hamdouch K, Ortiz M, Astola A: CENPA a genomic marker for centromere activity and human diseases. Curr. Genomics 2009, 10:326-335.
58. Jeffery IB, Higgins DG, Culhane AC: Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics 2006, 7:359.
59. Tsuruoka S, Ishibashi K, Yamamoto H, Wakaumi M, Suzuki M, Schwartz GJ, Imai M, Fujimura A: Functional analysis of ABCA8, a new drug transporter. Biochem. Biophys. Res. Commun 2002, 298:41-45.
60. Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H, Hoffmann H: Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009, 63(1):32-8, Epub 2008 May 16.
61. Adler W, Brenning A, Potapov S, Schmid M, Lausen B: Ensemble classification of paired data. Comput. Stat. Data Anal 2011, 55:1933-1941.
62. Cancer GeneticsWeb. [http://www.cancerindex.org/geneweb/X1501.htm].
63. Siegel S, NJC Jr: Nonparametric Statistics for The Behavioral Sciences. McGraw-Hill Humanities/Social Sciences/Languages;, 2nd 1988.
64. Reiczigel J, Zakariás I, Rózsa L: A bootstrap test of stochastic equality of two populations. The American Statistician 2005, 59:156-161.
65. Storey JD: A direct approach to false discovery rates. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2002, 64:479-498.
66. XCluster. [http://genetics.stanford.edu/not, vert, similarsherlock/ cluster.html].
67. Saldanha AJ: Java Treeview-extensible visualization of microarray data. Bioinformatics 2004, 20:3246-3248.
68. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
69. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z, Galon J: ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25:1091-1093.
70. PANTHER Classification System. [http://www.pantherdb.org/].
71. MetaCore. [http://www.genego.com/metacore.php].
72. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods; 2001:25(4):402-8.